Lovastatin decreases the receptor-mediated degradation of acetylated and oxidized LDLs in human blood monocytes during the early stage of differentiation into macrophages

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 19, Issue 5, 1999, Pages 1267-1275

  Hrboticky, N ^a   Draude, G ^a   Hapfelmeier, G ^a   Lorenz, R ^a   Weber, P C ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

3 hydroxy 3 methylglutaryl coenzyme A reductase inhibitor; Acetylated LDL; CD36; LDL receptor; Monocyte; Oxidized LDL; Scavenger receptor

Indexed keywords

CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MEVINOLIN; SCAVENGER RECEPTOR;

ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL DIFFERENTIATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; LIPOPROTEIN METABOLISM; MACROPHAGE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING; RECEPTOR UPREGULATION;

EID: 0032941385     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.19.5.1267     Document Type: Article

References (53)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature. 1993;362:801-806.
2. Brown MS, Goldstein JS. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu. Rev Biochem. 1983;52:223-261.
3. Krieger M. Molecular flypaper, host defence and atherosclerosis: structure, binding properties, and functions of macrophage scavenger receptors. J Biol Chem. 1993;268:4569-4572.
4. Geng Y, Kodama T, Hansson GK. Differential expression of scavenger receptor isoforms during monocyte-macrophage differentiation and foam cell formation. Arterioscler Thromb. 1994;14:798-806.
5. Nozaki S, Kashiwagi H, Yamashita S, Nakagawa T, Kostner B, Tomiyama Y, Nakata A, Ishigami M, Miyagawa J, Kameda-Takemura K, Kurata Y, Matsuzawa Y. Reduced uptake of oxidized low density lipoprotein in monocyte-derived macrophages from CD36-deficient subjects. J Clin Invest. 1995;96:1859-1865.
6. Nicholson AC, Frieda S, Pearce A, Silverstein RL. Oxidized LDL binds to CD36 on human monocyte-derived macrophages and transfected cell lines: evidence implicating the lipid moiety of the lipoprotein as the binding site. Arterioscler Thromb Vasc Biol. 1995;15:269-275.
7. Steinberg D. Low density lipoprotein and its pathobiological significance. J Biol Chem. 1997;272:20963-20966.
8. Suzuki H, Kurihara Y, Takeya M, et al. A role for macrophage scavenger receptors in atherosclerosis and susceptibility to infection. Nature. 1997; 386:292-296.
9. Villanova JG, Lucena JLD, Arcas NF, Engel AR. Increased expression of scavenger receptor type 1 gene in human peripheral blood from hyperlipidemic patients determined by quantitative additive RT-PCR. Biochim Biophys Acta. 1996;1300:135-141.
10. Endemann G, Stanton LW, Madden KS, Bryant CM, White RT, Protter AA. CD36 is a receptor for oxidized low density lipoprotein. J Biol Chem. 1993;268:11811-11816.
11. Vaughan, CJ, Murphy MB, Buckley BM. Statins do more than lower cholesterol. Lancet. 1996;348:1079-1082.
12. Keidar S, Aviram M, Maor I, Oiknine J, Brook G. Pravastatin inhibits cellular cholesterol synthesis and increases low density lipoprotein activity in macrophages: in vitro and in vivo studies. Br J Clin Pharmacol. 1994;38:513-519.
13. Raveh D, Israeli A, Arnon R, Eisenberg S. Effects of lovastatin therapy on LDL receptor activity in circulating monocytes and on structure and composition of plasma lipoproteins. Atherosclerosis. 1990;82:19-26.
14. Stone BG, Evans CD, Prigge WF, Daune WC, Gebhard RL. Lovastatin treatment inhibits sterol synthesis and induced HMG-CoA reductase activity in mononuclear monocytes of normal subjects. J Lipid Res. 1989;30:1943-1952.
15. Kempen HJM, Vermeer M, deWit E, Havekes LM. Vastatins inhibit cholesterol ester accumulation in human monocyte-derived macrophages. Arterioscler Thromb. 1991;11:146-153.
16. Bernini F, Scurati N, Bonfadini G, Fumagalli R. HMG-CoA reductase inhibitors reduce acetyl LDL endocytosis in mouse peritoneal macrophages. Arterioscler Thromb Vasc Biol 1995;15:1352-1358.
17. Umetani N, Kanayama Y, Okamura M, Negoro N, Takeda T. Lovastatin inhibits gene expression of type-I scavenger receptor in THP-1 human macrophages. Biochim Biophys Acta. 1996;1303:199-206.
18. Bernini F, Didoni G, Bonfadini G, Bellosta S, Fumagalli R. Requirement for mevalonate in acetylated LDL induction of cholesterol esterification in macrophages. Atherosclerosis. 1993;104:19-26.
19. Pietsch A, Erl W, Lorenz RL. Lovastatin reduces the expression of the combined adhesion and scavenger receptor CD36 in human monocytic cells Biochem Pharmacol. 1996;52:433-439.
20. Fogelman AM, Haberland ME, Seager J, Hokom M, Edwards PA. Factors regulating the activities of the low density lipoprotein receptor and the scavenger receptor on human monocyte-macrophages. J Lipid Res. 1981; 22:1131-1141.
21. Alessio M, De Monte L, Scirea A, Gruarin P, Tandon NN, Sitia R. Synthesis, processing and intracellular transport of CD36 during monocytic differentiation. J Biol Chem. 1996;271:1770-1775.
22. Eierman DF, Johnson CE, Haskill SJ. Human monocyte inflammatory mediator gene expression is selectively regulated by adherence substrates. J Immunol. 1989;142:1970-1976.
23. Basu SK, Goldstein JL, Anderson RG, Brown MS. Degradation of cationized LDL and regulation of cholesterol metabolism in homozygous familial hypercholesterolemia fibroblasts. Proc Natl Acad Sci U S A. 1976;73:3178-3182.
24. Bilheimer D, Eisenberg S, Levy R. The metabolism of very low density lipoprotein proteins. I: Preliminary in vitro and in vivo observations. Biochem Biophys Acta. 1972; 260:212-221.
25. Markwell MAK, Haas SM, Bieber LL, Telbert MEA. Modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem. 1987;87:206-210.
26. Danesch U, Weber PC, Sellmayer A. Arachidonic acid increases c-fos and Erg-1 mRNA in 3T3 Fibroblasts by formation of prostaglandin E2 and activation of protein kinase C. J Biol Chem. 1994;269:27258-27263.
27. Matsumoto A, Naito M, Itakura H, Ikemoto S, Asaoka H, Hayakawa I, Kanamori H, Abruatani H, Takaku F, Suzuki H, Kobari Y, Miyai T, Takahashi K, Cohen EH, Wydro R, Housman DE, Kodama T. Human macrophage scavenger receptors: primary structure, expression, and localization in atherosclerotic lesions. Proc Natl Acad Sci U S A. 1990; 87:9133-9137.
28. Goldstein JL, Russel DW. The human LDL receptor: a cysteine-rich protein with multiple Alu sequences in its mRNA. Cell. 1984;39:27-38.
29. Oquendo P, Hundt E, Lawier J, Seed B. CD36 directly mediates cytoadherence of plasmodium falciparum parasitized erythrocytes. Cell. 1989; 58:95-101.
30. Ponte P, Ng SY, Engel J, Gunning P, Kedes L. Evolutionary conservation in the untranslated regions of actin mRNAs: DNA sequence of a human beta-actin cDNA. Nucleic Acids Res. 1984;12:1687-1696.
31. van der Kooij MA, van der Mark EM, Kruijt JK, van Velzen A, van Berkel TJC, Morand OH. Human monocyte-derived macrophages express a 120 kDa ox LDL binding protein with strong identity to CD68. Arterioscler Thromb Vasc Biol. 1997;17:3107-3116.
32. Hoppe G, O'Neil J, Hoff HF. Inactivation of lysosomal proteases by oxidized low density lipoprotein is partially responsible for its poor degradation by mouse peritoneal macrophages. J Clin Invest. 1994;94: 1506-1512.
33. Lougheed M, Steinbrecher UP. Mechanism of uptake of copper-oxidized low-density lipoprotein in macrophages is dependent on its extent of oxidation. J Biol Chem. 1996;271:11798-11805.
34. Hoff HF, Whitaker TE, O'Neil J. Oxidation of low density lipoprotein leads to particle aggregation and altered macrophage recognition. J Biol Chem. 1992;267:602-609.
35. Kaplan G, Gaudemack G. In vitro differentiation of human monocytes: differences in monocyte phenotypes induced by cultivation on glass and collagen. J Exp Med. 1982;156:1101-1114.
36. Goldstein JL, Brown MS. Regulation of the mevalonate pathway. Nature. 1990;343:425-430.
37. Hoff HF, O'Neil J. Lesion-derived low density lipoprotein and oxidized low density lipoprotein share a lability for aggregation, leading to enhanced macrophage degradation. Arterioscler Thromb. 1991;11: 1209-1222.
38. Stanton LW, White RT, Bryant CM, Protter AA, Endemann G. A macrophage Fc receptor for IgG is also a receptor for oxidized low density lipoprotein. J Biol Chem. 1992;31:22446-22451.
39. Acton SL, Scherer PE, Lodish HF, Krieger M. Expression cloning of SR-BI, a CD36-related class B scavenger receptor. J Biol Chem. 1994; 269:21003-21009.
40. Ramprasad MP, Fischer W, Witztum JL, Sambrano GR, Quehenberger O, Steinberg D. The 94-to 97-kDa mouse macrophage membrane protein that recognizes oxidized low density lipoprotein and phosphatidylserine-rich liposomes is identical to macrosialin, the mouse homologue of human CD68. Proc Natl Acad Sci U S A. 1995;92:9580-9587.
41. Horvai AE, Xu L, Korzus E, Brard G, Kalafus D, Mullen TM, Rose DW, Rosenfeld MG, Glass C. Nuclear integration of JAK/STAT and Ras/AP-1 signalling by CBP and p300. Proc Natl Acad Sci U S A. 1997;94: 1074-1079.
42. Armesilla AL, Calvo D, Vega MA. Structural and functional characterization of the human CD36 gene promoter. J Biol Chem. 1996;271: 7781-7787.
43. Giroux LM, Davignon J, Naruszewicz M. Simvastatin inhibits the oxidation of low-density-lipoproteins by activated human monocyte-derived macrophages. Biochim Biophys Acta. 1993;1165:335-338.
44. Sakai M, Kobori S, Matsumura T, Biwa T, Sato Y, Takemura T, Hakamata H, Horiuchi S, Shichiri M. HMG-CoA reductase inhibitors suppress macrophage growth induced by oxidized low density lipoprotein. Atherosclerosis. 1997;133:51-59.
45. Mietus-Snyder M, Friera A, Glass CK, Pitas RE. Regulation of scavenger receptor expression in smooth muscle cells by protein kinase C: a role for oxidative stress. Arterioscler Thromb Vasc Biol. 1997;17:969-978.
46. Han J, Hajjar DP, Febbraio M, Nicholson AC. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36. J Biol Chem. 1997;272:21654-21659.
47. Yoshida H, Quehenberger O, Kondratenko N, Green S, Steinberg D. Minimally oxidized low density lipoprotein increases expression of scavenger receptor A, CD36, and Macrosialin in resident mouse peritoneal macrophages. Arterioscler Thromb Vasc Biol. 1998;18:794-802.
48. van Lenten BJ, Fogelman AM. Lipopolysaccharide-induced inhibition of scavenger receptor expression in human monocyte-macrophages is mediated through tumor necrosis factor-34. J Immunol. 1992;148: 112-116.
49. Weber C, Erl W, Weber KSC, Weber PC. HMG-CoA reductase inhibitors decrease CD11b expression and CD11b-dependent adhesion of monocytes to endothelium and reduce increased adhesiveness of monocytes isolated from patients with hypercholesterolemia. J Am Coll Cardiol. 1997;30:1212-1217.
50. Fong LG. Modulation of macrophage scavenger receptor transport by protein phosphorylation. J Lipid Res. 1996;37:574-587.
51. Lamaze C, Chuang TH, Terlecky LJ, Bokoch GM, Schmid SL. Regulation of receptor-mediated endocytosis by Rho and Rac. Nature. 1996; 382:177-179.
52. Bucci C, Parton RG, Mather IH, Stunnenberg H, Simons K, Hoflack B, Zerial M. The small GTPase rab5 functions as a regulatory factor in the early endocytic pathway. Cell. 1992;70:715-728.
53. Vitelli R, Santillo M, Lattero D, Chiariello M, Bifulco M, Bruni CB, Bucci C. Role of the small GTPase RAB7 in the late endocytic pathway. J Biol Chem. 1997;272:4391-4397.